Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Profile of Alexander Y. Rudensky, winner of the 2018 Vilcek Prize in Biomedical Science.

Nair P, Vilcek J.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4301-4304. doi: 10.1073/pnas.1804659115. Epub 2018 Apr 9. No abstract available.

2.

Profile of Lily and Yuh Nung Jan, winners of the 2017 Vilcek Prize in Biomedical Science.

Nair P, Vilcek J.

Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1748-1752. doi: 10.1073/pnas.1621487114. Epub 2017 Feb 6. No abstract available.

3.

Profile of Dan Littman, winner of the 2016 Vilcek Prize in Biomedical Science.

Nair P, Vilcek J.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2798-802. doi: 10.1073/pnas.1600099113. Epub 2016 Feb 22. No abstract available.

4.

The long road to renown: the 2015 Vilcek Foundation Prizes.

Nair P, Vilcek J.

FASEB J. 2015 Mar;29(3):733-9. doi: 10.1096/fj.15-0301ufm. No abstract available.

PMID:
25733691
5.

Journey to the summits of science: the 2014 Vilcek Foundation prizes.

Nair P, Vilcek J.

FASEB J. 2014 Mar;28(3):1035-40. doi: 10.1096/fj.14-0301ufm. No abstract available.

PMID:
24578136
6.

Foreign minds, fenceless imagination: the 2013 Vilcek Foundation Prizes.

Nair P, Vilcek J.

FASEB J. 2013 Mar;27(3):845-52. doi: 10.1096/fj.13-0301ufm. No abstract available.

PMID:
23450005
7.

Gems from distant shores: the 2012 Vilcek Foundation prizes.

Nair P, Vilcek J.

FASEB J. 2012 Apr;26(4):1361-6. doi: 10.1096/fj.12-0402ufm. No abstract available.

PMID:
22467904
8.

From IFN to TNF: a journey into realms of lore.

Vilcek J.

Nat Immunol. 2009 Jun;10(6):555-7. doi: 10.1038/ni0609-555. No abstract available.

PMID:
19448652
9.

First demonstration of the role of TNF in the pathogenesis of disease.

Vilcek J.

J Immunol. 2008 Jul 1;181(1):5-6. No abstract available.

10.

IRF1: a deus ex machina in TH1 differentiation.

Unutmaz D, Vilcek J.

Nat Immunol. 2008 Jan;9(1):9-10. No abstract available.

PMID:
18087248
11.

Interferon research BC (before cloning).

Vilcek J.

Curr Top Microbiol Immunol. 2007;316:9-22. Review.

PMID:
17969441
12.

My fifty years with interferon.

Vilcek J.

J Interferon Cytokine Res. 2007 Jul;27(7):535-42. No abstract available.

PMID:
17651014
13.

Fifty years of interferon research: aiming at a moving target.

Vilcek J.

Immunity. 2006 Sep;25(3):343-8. Review.

14.

A prize for the foreign-born.

Vilcek J, Cronstein BN.

FASEB J. 2006 Jul;20(9):1281-3. No abstract available.

PMID:
16816100
15.

Up-regulation of cyclooxygenase-2 expression by TSG-6 protein in macrophage cell line.

Mindrescu C, Le J, Wisniewski HG, Vilcek J.

Biochem Biophys Res Commun. 2005 May 13;330(3):737-45.

PMID:
15809059
16.

TSG-6 protein binding to glycosaminoglycans: formation of stable complexes with hyaluronan and binding to chondroitin sulfates.

Wisniewski HG, Snitkin ES, Mindrescu C, Sweet MH, Vilcek J.

J Biol Chem. 2005 Apr 15;280(15):14476-84. Epub 2005 Feb 7.

17.

Why are rabbits uniquely sensitive to myxoma virus? Cherchez l'interferon!

Vilcek J.

Nat Immunol. 2004 Dec;5(12):1205-6. No abstract available.

PMID:
15549119
18.

Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase.

Szatmáry Z, Garabedian MJ, Vilcek J.

J Biol Chem. 2004 Oct 15;279(42):43708-15. Epub 2004 Aug 2.

19.

Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14.

Wisniewski HG, Vilcek J.

Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):129-46. Review.

PMID:
15110797
20.

Historical review: Cytokines as therapeutics and targets of therapeutics.

Vilcek J, Feldmann M.

Trends Pharmacol Sci. 2004 Apr;25(4):201-9.

PMID:
15063084
21.

Reassessing the usual suspects causing a commotion in the blood (and vessels?).

Wolchok JD, Vilcek J.

Cancer Biol Ther. 2004 Jan;3(1):124-5. Epub 2004 Jan 9. Review. No abstract available.

PMID:
14739778
22.

Boosting p53 with interferon and viruses.

Vilcek J.

Nat Immunol. 2003 Sep;4(9):825-6. No abstract available.

PMID:
12942081
23.

Novel interferons.

Vilcek J.

Nat Immunol. 2003 Jan;4(1):8-9. No abstract available.

PMID:
12496969
24.
25.

TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis.

Dias AA, Goodman AR, Dos Santos JL, Gomes RN, Altmeyer A, Bozza PT, Horta MF, Vilcek J, Reis LF.

J Leukoc Biol. 2001 Jun;69(6):928-36.

PMID:
11404378
27.

Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.

Mindrescu C, Thorbecke GJ, Klein MJ, Vilcek J, Wisniewski HG.

Arthritis Rheum. 2000 Dec;43(12):2668-77.

28.
29.

Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages.

Goodman AR, Levy DE, Reis LF, Vilcek J.

J Leukoc Biol. 2000 Mar;67(3):387-95.

PMID:
10733100
30.
31.
32.

Cell-type-specific activation of c-Jun N-terminal kinase by salicylates.

Schwenger P, Alpert D, Skolnik EY, Vilcek J.

J Cell Physiol. 1999 Apr;179(1):109-14.

PMID:
10082138
33.

Forty years of interferon, forty years of cytokines.

Vilcek J.

Cytokine Growth Factor Rev. 1997 Dec;8(4):239. No abstract available.

PMID:
9620639
35.

TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity.

Wisniewski HG, Vilcek J.

Cytokine Growth Factor Rev. 1997 Jun;8(2):143-56. Review.

PMID:
9244409
36.
37.

Long pentraxins: an emerging group of proteins with diverse functions.

Goodman AR, Cardozo T, Abagyan R, Altmeyer A, Wisniewski HG, Vilcek J.

Cytokine Growth Factor Rev. 1996 Aug;7(2):191-202. Review.

PMID:
8899296
38.

Cytokines in 1995.

Vilcek JT.

Cytokine Growth Factor Rev. 1996 Jun;7(1):103-6. No abstract available.

PMID:
8864358
39.

The inauguration of Cytokine & Growth Factor Reviews.

Sporn MB, Vilcek JT.

Cytokine Growth Factor Rev. 1996 Jun;7(1):1. No abstract available.

PMID:
8864348
40.
41.

TSG-6 expression in human articular chondrocytes. Possible implications in joint inflammation and cartilage degradation.

Maier R, Wisniewski HG, Vilcek J, Lotz M.

Arthritis Rheum. 1996 Apr;39(4):552-9.

PMID:
8630102
42.
43.

TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo.

Wisniewski HG, Hua JC, Poppers DM, Naime D, Vilcek J, Cronstein BN.

J Immunol. 1996 Feb 15;156(4):1609-15.

PMID:
8568267
44.

TSG-6, a glycoprotein associated with arthritis, and its ligand hyaluronan exert opposite effects in a murine model of inflammation.

Wisniewski HG, Naime D, Hua JC, Vilcek J, Cronstein BN.

Pflugers Arch. 1996;431(6 Suppl 2):R225-6.

PMID:
8739346
45.
46.
47.

Activation of the TSG-6 gene by NF-IL6 requires two adjacent NF-IL6 binding sites.

Klampfer L, Chen-Kiang S, Vilcek J.

J Biol Chem. 1995 Feb 24;270(8):3677-82.

48.

Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor.

Kamijo R, Gerecitano J, Shapiro D, Green SJ, Aguet M, Le J, Vilcek J.

J Inflamm. 1995-1996;46(1):23-31.

PMID:
8832969
49.

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.

Siegel SA, Shealy DJ, Nakada MT, Le J, Woulfe DS, Probert L, Kollias G, Ghrayeb J, Vilcek J, Daddona PE.

Cytokine. 1995 Jan;7(1):15-25.

PMID:
7538333
50.

Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice.

Kamijo R, Shapiro D, Gerecitano J, Le J, Bosland M, Vilcek J.

Hokkaido Igaku Zasshi. 1994 Nov;69(6):1332-8.

PMID:
7705746

Supplemental Content

Loading ...
Support Center